UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000012117 |
|---|---|
| Receipt number | R000014171 |
| Scientific Title | Efficacy and safety of rush immunotherapy for Japanese cedar pollinosis |
| Date of disclosure of the study information | 2013/10/27 |
| Last modified on | 2016/04/25 10:09:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy and safety of rush immunotherapy for Japanese cedar pollinosis
Acronym
Efficacy and safety of rush immunotherapy for Japanese cedar pollinosis
Scientific Title
Efficacy and safety of rush immunotherapy for Japanese cedar pollinosis
Scientific Title:Acronym
Efficacy and safety of rush immunotherapy for Japanese cedar pollinosis
Region
| Japan |
Condition
Condition
Japanese cedar pollinosis
Classification by specialty
| Pediatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluate the efficacy and safety of rush immunotherapy for Japanese cedar pollinosis in children
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Symptom score, Medication score, QOL score, Adverse reaction
Key secondary outcomes
Change of parameters in blood
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Administration standardized Japanese cedar extract to maintenance phase for a week
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 5 | years-old | <= |
Age-upper limit
| 20 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1) Patient with allergic rhinitis, who have specific IgE RAST score 2 or skin prick test positive for cedar pollen.
2) Patient who have typical allergic rhinitis symptoms year.
3) Written informed consent is required.
Key exclusion criteria
1) Patients who have received immunotherapy.
2) Uncontrolled asthma patients.
3) Patients who were judged to be unsuitable for patient enrollment by their doctor.
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Motohiro Ebisawa |
Organization
National Sagamihara Hospital
Division name
Department of Allergy, Clinical Research Center for Allergology and Rheumatology
Zip code
Address
18-1, Sakuradai, Minami-ku, Sagamihara, Kanagawa 252-0392, Japan
TEL
042-742-8311
m-ebisawa@sagamihara-hosp.gr.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Tomoyuki Asaumi |
Organization
National Sagamihara Hospital
Division name
Pediatrics
Zip code
Address
18-1, Sakuradai, Minami-ku, Sagamihara, Kanagawa 252-0392, Japan
TEL
042-742-8311
Homepage URL
ocean19oranges@yahoo.co.jp
Sponsor or person
Institute
National Sagamihara Hospital
Institute
Department
Personal name
Funding Source
Organization
self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
none
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 10 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2013 | Year | 10 | Month | 27 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 10 | Month | 27 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 10 | Month | 25 | Day |
Last modified on
| 2016 | Year | 04 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014171
